Methods of treating nasal airways
A device is described for treating a nasal airway by modifying a property of a nasal tissue of or near a nasal valve of the airway, without using a surgical incision or an implant, to decrease airflow resistance or perceived airflow resistance in the nasal airway. Various embodiments include an elongate shaft, a bipolar radiofrequency delivery member extending from one end of the shaft, and a handle attached to the elongate shaft at an opposite end from the radiofrequency delivery member. The radiofrequency delivery member is sized to be inserted into a nose and configured to at least temporarily deform the nasal tissue and deliver radiofrequency energy. The radiofrequency delivery member includes two rows of protruding electrodes disposed on a tissue contact surface, and the device is configured to deliver radiofrequency energy from one row of electrodes to the other row of electrodes.
1. A method for treating a nasal airway to reduce mucus production, the method comprising:
inserting a cryotherapy balloon of a nasal airway treatment device into the nasal airway of a patient having nasal airflow resistance caused by rhinitis;
inflating the cryotherapy balloon to an inflated configuration with a cryogenic substance to cause the cryotherapy balloon to contact nasal mucosa of the nasal airway;
damaging a target tissue underlying the nasal mucosa by removing energy from the target tissue with the inflated cryotherapy balloon;
deflating the cryotherapy balloon; and
removing the cryotherapy balloon from the nasal airway,
wherein damaging the target tissue deactivates muscle tissue and causes a reduction in mucus production in the nasal airway.
2. The method of claim 1 , wherein the target tissue is selected from the group consisting of submucosa, cartilage, muscle, ligament, and tendon.
3. The method of claim 1 , wherein the target tissue is located at a selected tissue depth below the nasal mucosa.
4. The method of claim 1 , further comprising:
sensing a temperature of the nasal mucosa using a thermocouple; and
modifying an amount of the energy removed from the target tissue based on the sensed temperature.
5. The method of claim 1 , further comprising displaying one or more parameters of treatment on a control system attached to the nasal airway treatment device while the cryotherapy balloon remains inflated in the nasal airway, the one or more parameters selected from the group consisting of treatment time, power level, temperature of the nasal mucosa, temperature of the cryogenic substance, and depth of treatment.
6. The method of claim 1 , further comprising applying local anesthesia to at least one of the nasal mucosa or the target tissue before inflating the cryotherapy balloon.
7. The method of claim 1 , further comprising maintaining the cryotherapy balloon in the inflated configuration in the nasal airway for a treatment time of between fifteen seconds and three minutes.
8. The method of claim 7 , further comprising circulating the cryogenic substance through the cryotherapy balloon while it is maintained in the inflated configuration.
9. The method of claim 1 , further comprising, before removing the cryotherapy balloon from the nasal airway:
repositioning the deflated cryotherapy balloon; and
inflating the repositioned cryotherapy balloon with the cryogenic substance to contact a different portion of nasal mucosa and remove energy from a different portion of target tissue underlying the different portion of nasal mucosa.
10. The method of claim 1 , further comprising repositioning, remodeling, or reshaping the target tissue with the cryotherapy balloon, wherein the target tissue remains at least partially repositioned, remodeled or reshaped after the target tissue heals.
11. The method of claim 1 , wherein the cryogenic substance is a liquid.
12. The method of claim 1 , wherein the cryogenic substance is a gas.